Serum cystatin-C: a better predictor of decreased creatinine clearance than serum creatinine in cancer patients on cisplatin
Annals Abbassi Shaheed Hospital and Karachi Medical and Dental College. 2002; 7: 278-85
en Inglés
| IMEMR
| ID: emr-58893
ABSTRACT
To observe the effects of acute deterioration in GFR, induced by cisplatin, on the levels of serum creatinine and cystatin C and to correlate the level of serum creatinine and cystatin C among cancer patients and the controls. Design:
It is a comparative study carried out in the Department of physiology, Basic Medical Sciences Institute, Jinnah Postgraduate medical Centre, Karachi.Subjects:
Seventy subjects were included in the study. Group I comprising of cancer patients with GFR greater than 80 ml/min/1.73m2 and group II comprising of cancer patients with GFR less than 80 ml/min/1.73m2. Estimations of serum creatinine, urinary creatinine and cystatin C in all subjects were done twice, first before the start of chemotherapy with cisplatin and second before the start of second cycle.Result:
A highly significant correlation was found between the reciprocals of the levels of cystatin C and creatinine clearance as compared to a less significant Pvalue, which was found between the reciprocals of the levels of creatinine and creatinine clearance. In conclusion, the results of this study emphasizes that serum cystatin C is a promising endogenous marker of GFR, and it might be of particular interest in patients with slightly decreased renal functions
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Cisplatino
/
Creatinina
/
Tasa de Filtración Glomerular
/
Neoplasias
Límite:
Humanos
Idioma:
Inglés
Revista:
Ann. Abbassi Shaheed Hosp. Karachi Med. Dent. Coll.
Año:
2002
Similares
MEDLINE
...
LILACS
LIS